Case examples of quantitative plaque analysis on coronary CT angiography and 18F-NaF PET in patients with established coronary artery disease. Hybrid CT angiography and 18F-NaF PET of coronary arteries. (A) A 70-y-old male, who presented with diffused largely noncalcified disease (middle panel in red) in the LAD and demonstrated increased 18F-NaF uptake in the LAD on PET. (B) A 59-y-old male with mild LCX atherosclerosis, who presented with a high noncalcified plaque burden (middle panel in red) on CT angio

Case examples of quantitative plaque analysis on coronary CT angiography and 18F-NaF PET in patients with established coronary artery disease. Hybrid CT angiography and 18F-NaF PET of coronary arteries. (A) A 70-y-old male, who presented with diffused largely noncalcified disease (middle panel in red) in the LAD and demonstrated increased 18F-NaF uptake in the LAD on PET. (B) A 59-y-old male with mild LCX atherosclerosis, who presented with a high noncalcified plaque burden (middle panel in red) on CT angiography, significant 18F-NaF uptake and experienced a lateral non–ST-segment elevation myocardial infarction during follow-up. LAD = left anterior descending; LCX = left circumflex; LAP = low attenuation plaque. Image courtesy of first author Jacek Kwiecinski and senior author Piotr Slomka, Cedars-Sinai, Los Angeles, Calif., in collaboration with Edinburgh University, UK.


January 12, 2022 — By combining information from two advanced imaging techniques with clinical data, physicians can improve their prediction of heart attacks, according to research published in the January issue of The Journal of Nuclear Medicine. When assessed together in an artificial intelligence model, coronary 18F-NaF uptake on PET and quantitative coronary plaque characteristics on CT angiography were found to be complementary, strong predictors of heart attack risk in patients with established coronary artery disease, providing risk prediction superior to that of clinical data alone.

In everyday clinical practice, predicting a heart attack is challenging. The predicted likelihood of a heart attack typically is based on cardiovascular risk factors and scores, especially in patients with suspected coronary artery disease. However, in patients with confirmed coronary artery disease, cardiovascular risk factors and scores don’t always show the full picture.

“Recently, advanced imaging techniques have demonstrated considerable promise in determining which coronary artery disease patients are most at risk for a heart attack. These techniques include 18F-sodium fluoride (18F-NaF) PET, which assesses disease activity in the coronary arteries, and CT angiography, which provides a quantitative plaque analysis,” said Piotr J. Slomka, PhD, FACC, FASNC, FCCPM, director of Innovation in Imaging at Cedars-Sinai Medical Center in Los Angeles, Calif. “Our goal in the study was to investigate whether the information provided by 18F-NaF PET and CT angiography is complementary and could improve prediction of heart attacks with the use of artificial intelligence techniques.”

Nearly 300 patients with established coronary atherosclerosis participated in the study. All patients underwent a baseline clinical assessment with evaluation of their cardiovascular risk factor profile. All patients received hybrid coronary 18F-NaF PET and contrast CT coronary angiography. Machine learning—a type of artificial intelligence—was used to calculate a joint score for heart attack risk by incorporating key variables from the clinical assessment, 18F-NaF PET findings and quantitative CT variables.

The machine learning model showed substantial improvement in prediction of heart attack over clinical data alone. This approach demonstrated that 18F-NaF PET and CT angiography are complementary and additive, with the combination of both providing the most robust outcome prediction.

18F-NaF PET combined with anatomical imaging provided by CT angiography has the potential to enable precision medicine by guiding the use of advanced therapeutic interventions,” noted Slomka. “Our study supports the use of artificial intelligence methods for integrating multimodality imaging and clinical data for robust prediction of heart attacks.”

For more information: www.snmmi.org

Related Multimodality Imaging Content:

Deep Learning with SPECT Accurately Predicts Major Adverse Cardiac Events

Using Contrast MRI After a Heart Attack Could Increase Survival

Medical Societies Support Safety and Benefits of Ultrasound Contrast Agents

Related Content

Feature | Nuclear Imaging

The "Nuclear Medicine Market Size, Share & Trends Analysis Report by Product (Diagnostics (SPECT, PET)), Therapeutics ...

Time May 26, 2022
arrow
News | Radiopharmaceuticals and Tracers

May 16, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time May 16, 2022
arrow
News | Contrast Media

May 13, 2022 — The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware ...

Time May 13, 2022
arrow
News | Radiology Business

May 11, 2022 — Enlitic, a leading AI healthcare company, has welcomed Dave Wilson as the vice president of marketing and ...

Time May 11, 2022
arrow
News | Coronavirus (COVID-19)

May 4, 2022 — While the COVID-19 pandemic transitions through various phases, nuclear cardiology teams should maintain a ...

Time May 04, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 3, 2022 — More than 60 million magnetic resonance imaging (MRI) scans are performed worldwide each year, but imaging ...

Time May 04, 2022
arrow
News | Radiation Therapy

May 4, 2022 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) ...

Time May 04, 2022
arrow
News | Cardiac Imaging

May 2, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), routine visual ordinal coronary artery calcium ...

Time May 02, 2022
arrow
News | Cardiac Imaging

April 28, 2022 — Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce ...

Time April 28, 2022
arrow
News | Prostate Cancer

April 15, 2022 — Prostate cancer is the most common malignant tumor in men in Germany, with about 62,000 new cases ...

Time April 14, 2022
arrow
Subscribe Now